Sabby Management’s Sonnet BioTherapeutics SONN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-29,799
| Closed | -$223K | – | 51 |
|
2024
Q2 | $223K | Buy |
+29,799
| New | +$223K | 0.15% | 10 |
|
2023
Q3 | – | Sell |
-18,699
| Closed | -$1.61M | – | 90 |
|
2023
Q2 | $1.61M | Buy |
18,699
+11,793
| +171% | +$1.02M | 1.32% | 3 |
|
2023
Q1 | $438K | Buy |
+6,906
| New | +$438K | 0.38% | 21 |
|